Phibro Animal Health (PAHC)
Sells medicated feed additives, vaccines, nutritional specialties, and trace minerals for animal production.
$35.37
vs last close+0.69 (+2.00%)
In millions of USD, except per-share figures
| In millions | Q1 FY24Sep 2023 | Q2 FY24Dec 2023 | Q3 FY24Mar 2024 | Q4 FY24Jun 2024 | Q1 FY25Sep 2024 | Q2 FY25Dec 2024 | Q3 FY25Mar 2025 | Q4 FY25Jun 2025 | Q1 FY26Sep 2025 | Q2 FY26Dec 2025 | Q3 FY26Mar 2026 | Q4 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 231 | 250 | 263 | 273 | 260 | 309 | 348 | 379 | 364 | 374 | 384 | 397 |
| Cost of revenue | 164 | 171 | 184 | 186 | 177 | 207 | 243 | 269 | 244 | 241 | 258 | 262 |
| Gross profit | 68 | 79 | 80 | 87 | 83 | 102 | 105 | 110 | 120 | 133 | 125 | 134 |
| 68 | 63 | 60 | 69 | 66 | 76 | 71 | 76 | 71 | 78 | 77 | 86 | |
| 68 | 63 | 60 | 69 | 66 | 76 | 71 | 76 | 71 | 78 | 77 | 86 | |
| General & administrative | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 86 |
| Operating income | −1 | 16 | 20 | 18 | 18 | 26 | 34 | 34 | 48 | 54 | 48 | 48 |
| −11 | −12 | −7 | −12 | −8 | −21 | −4 | −10 | −12 | −18 | −16 | −16 | |
| Interest income | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
| Interest expense | 9 | 9 | 9 | 6 | 8 | 9 | 13 | 8 | 13 | 13 | 11 | 10 |
| Other non-operating income | 6 | 7 | 2 | 6 | 0 | 12 | −5 | 1 | −2 | 5 | 5 | 6 |
| Income before tax | −12 | 4 | 13 | 6 | 10 | 5 | 30 | 24 | 36 | 36 | 32 | 32 |
| Income tax expense | −4 | 2 | 5 | 6 | 3 | 2 | 9 | 7 | 10 | 9 | 8 | 11 |
| Net income from continuing operations | −8 | 1 | 8 | 1 | 7 | 3 | 21 | 17 | 27 | 27 | 24 | 22 |
| Net income | −8 | 1 | 8 | 1 | 7 | 3 | 21 | 17 | 27 | 27 | 24 | 22 |
| EPS, basic | −$0.20 | $0.03 | $0.21 | $0.02 | $0.17 | $0.08 | $0.52 | $0.42 | $0.65 | $0.68 | $0.59 | $0.54 |
| EPS, diluted | −$0.20 | $0.03 | $0.21 | $0.02 | $0.17 | $0.08 | $0.51 | $0.42 | $0.65 | $0.67 | $0.59 | $0.53 |
| Weighted average shares, basic | 41 | 41 | 41 | 41 | 41 | 41 | 41 | 41 | 41 | 41 | 41 | 41 |
| Weighted average shares, diluted | 41 | 41 | 41 | 41 | 41 | 41 | 41 | 41 | 41 | 41 | 41 | 41 |
| EBITDA | 2 | 18 | 28 | 21 | 27 | 26 | 51 | 45 | 63 | 62 | 56 | 56 |
| Depreciation & amortization | 9 | 9 | 9 | 9 | 9 | 12 | 13 | 12 | 13 | 13 | 12 | 13 |
| EBIT | −7 | 9 | 18 | 12 | 18 | 14 | 39 | 32 | 50 | 49 | 43 | 43 |